Merck Manuals Details Key Facts to Know About Multiple Sclerosis
07 Feb 2024
RAHWAY, N.J., Feb. 7, 2024 /PRNewswire/ -- Multiple sclerosis (MS) may be a common disorder, but the journey to diagnosis and understanding of the illness may still lead to confusion for some patients.
In a new editorial from MerckManuals.com, Michael C. Levin, MD, College of Medicine, University of Saskatchewan, breaks down what patients and their families should know about MS, in order to educate themselves and prepare for conversations with a doctor.
1.
Several factors increase the likelihood of being diagnosed with MS
The cause of MS is unknown, but some studies point to early exposure to certain viruses in triggering the immune system to attack the body's own tissue.
2. Signs and symptoms vary – and may go away on their own
MS can affect any part of the brain or spinal cord, and symptoms can vary significantly from person to person and from episode to episode. Early symptoms may include:
Loss of strength or dexterity in a leg or hand, which may become stiff
Problems with vision
Symptoms may come on (known as relapses) and lessen (known as remission), seemingly without rhyme or reason.
3. Treatment can significantly reduce relapses
Individuals without a formal diagnosis may be tempted to ignore their illness, especially if symptoms have waned, says Levin. But he adds it's crucial to work to uncover the cause of symptoms and discuss them with a healthcare professional.
Once MS is diagnosed, treatment can significantly extend periods of remission. On average, most individuals experience a relapse every one or two years. But with treatment, that can be extended to 10 or even 20 years between relapses, says Levin. Based on the condition and its symptoms, neurologists can guide patients toward the most effective treatments and medications.
You can read more about MS in this editorial on MerckManuals.com.
About The Merck Manuals and MSD Manuals
First published in 1899 as a small reference book for physicians and pharmacists, The Merck Manual grew in size and scope to become one of the world's most widely used comprehensive medical resources for professionals and consumers. As The Manual evolved, it continually expanded the reach and depth of its offerings to reflect the mission of providing the best medical information to a wide cross-section of users, including medical professionals and students, veterinarians and veterinary students, and consumers. In 2015, The Manuals kicked off Global Medical Knowledge 2020, a global initiative with the goal to make the best current medical information accessible by up to three billion professionals and patients around the world by 2020. The Manuals achieved that goal, and today its medical information is available in nearly 250 countries and in 14 languages. It's continuing its ambitious mission through outreach, education and creating new reliable medical resources. For access to thousands of medical topics with images, videos and a constantly expanding set of resources, visit MerckManuals.com or MSDManuals.com and connect with us on social media: For Consumers in the U.S. and its territories: X (formerly Twitter) and Facebook. For Professionals in the U.S. and its territories: X (formerly Twitter) and Facebook
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
SOURCE The Merck Manuals
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.